Equities
Health CareMedical Equipment and Services
  • Price (USD)73.42
  • Today's Change-1.11 / -1.49%
  • Shares traded1.45m
  • 1 Year change+12.78%
  • Beta0.8234
Data delayed at least 15 minutes, as of Jul 11 2025 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Henry Schein, Inc. is a solutions company for healthcare professionals. Its segments consist of Global Distribution and Value-Added services, Global Specialty Services, and Global Technology. Global Distribution and Value-Added Services include the distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting and other services. This segment also markets and sells under its own brand, a portfolio of consumable merchandise. The Global Specialty Products includes the manufacturing, marketing and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products and other healthcare-related products and services. Global Technology includes the development and distribution of practice management software, e-services, and other products.

  • Revenue in USD (TTM)12.67bn
  • Net income in USD407.00m
  • Incorporated1992
  • Employees25.00k
  • Location
    Henry Schein Inc135 Duryea RdMELVILLE 11747United StatesUSA
  • Phone+1 (631) 843-5500
  • Fax+1 (302) 636-5454
  • Websitehttps://www.henryschein.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
HSIC:NSQ since
announced
Transaction
value
Acentus LLCDeal completed20 Nov 202420 Nov 2024Deal completed-1.90%--
ABC Dental AGDeal completed29 Jul 202429 Jul 2024Deal completed1.54%--
Data delayed at least 15 minutes, as of Jul 11 2025 21:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Merit Medical Systems Inc1.39bn122.26m5.53bn7.40k45.853.8722.783.982.042.0423.1224.180.57922.347.30187,615.805.103.495.543.9347.8045.378.815.653.2624.200.33840.007.896.4027.4885.69-14.13--
Lantheus Holdings Inc1.54bn254.32m5.63bn808.0023.074.8317.743.663.523.5221.6216.840.79087.964.481,901,855.0013.099.8714.9511.3364.0460.4416.5512.865.46--0.32750.0018.3234.59-4.3558.0629.27--
Glaukos Corp404.52m-123.68m5.93bn995.00--7.71--14.66-2.31-2.317.4213.460.42591.796.85406,555.80-13.02-11.24-14.06-12.0475.7573.54-30.57-36.685.62--0.083--21.8510.10-8.70--5.93--
Guardant Health Inc774.00m-416.55m6.23bn2.00k------8.04-3.38-3.386.28-2.030.50774.277.74387,191.60-27.33-24.20-32.00-26.8361.3463.23-53.82-91.243.76-38.581.29--31.0428.088.98--10.58--
Bruker Corp3.45bn79.60m6.64bn11.40k83.383.6523.731.930.52520.525222.8311.990.66021.565.74302,395.601.536.802.049.2049.2850.002.329.660.716413.770.533110.8713.5610.19-73.53-10.529.574.56
Stevanato Group SpA1.31bn146.67m6.88bn5.52k46.914.1629.075.230.53750.53754.826.060.49582.942.72238,105.605.538.027.0010.9428.7131.0111.1613.241.26--0.21746.821.7215.53-19.1324.6133.52--
Bio Rad Laboratories Inc2.54bn-2.16bn7.00bn7.70k--1.06--2.75-76.20-76.2090.48241.720.22961.505.84330,010.40-19.553.00-20.453.1553.6855.37-85.1714.514.430.10310.15250.00-3.922.11-189.37--13.91--
Repligen Corp650.43m-22.98m7.31bn1.78k--3.68104.5211.25-0.4124-0.412411.5735.340.22821.814.94365,820.60-0.80613.28-0.85573.7051.1554.24-3.5312.375.79--0.21060.000.328518.61-171.68--5.25--
Caris Life Sciences Inc452.50m-371.16m7.37bn--------16.28-1.34-1.341.63-1.27----------------46.71---60.43--0.8285-4.4216.39--34.67--18.22------
Globus Medical Inc2.51bn185.56m7.73bn5.30k42.731.8917.153.081.341.3418.1130.200.52011.054.70473,737.803.844.704.375.1869.0070.597.399.732.7220.570.00010.0060.6226.25-16.19-7.8810.29--
Masimo Corp1.97bn-276.60m8.84bn3.60k--9.33--4.48-5.17-9.2136.5117.460.75172.426.30548,222.30-10.543.29-13.173.9950.5053.94-14.024.561.622.120.40750.002.2617.43-474.11---6.75--
Henry Schein Inc12.67bn407.00m9.18bn25.00k22.822.7113.170.72443.223.22100.1227.081.234.917.86506,760.003.885.436.389.1931.6030.233.163.980.75256.940.37990.002.714.88-6.25-11.0619.66--
Penumbra Inc1.24bn42.23m9.21bn4.50k231.947.59145.277.431.031.0331.3831.350.78161.026.89275,577.802.661.422.951.5866.3763.213.411.963.68--0.0190.0012.8616.89-84.59-21.98-0.853--
Avantor Inc6.69bn715.60m9.25bn13.50k12.941.528.251.381.051.059.808.950.53295.696.01495,200.005.703.946.624.4833.5633.7610.706.870.75323.950.40240.00-2.642.35121.58--23.59--
Revvity Inc2.77bn296.04m11.96bn11.00k41.921.5916.774.322.422.3522.7063.960.21483.054.59251,806.202.304.312.494.8456.2558.5010.6915.782.9914.590.29326.520.162-0.908657.704.201.274.56
Solventum Corp8.31bn379.00m12.77bn22.00k33.923.9113.831.542.182.1847.6918.850.56834.267.74377,636.402.59--3.05--54.71--4.55--0.85231.930.7081--0.6954---64.41------
Data as of Jul 11 2025. Currency figures normalised to Henry Schein Inc's reporting currency: US Dollar USD

Institutional shareholders

44.38%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Mar 202514.23m11.46%
Artisan Partners LPas of 31 Mar 20256.41m5.16%
BlackRock Fund Advisorsas of 31 Mar 20256.26m5.04%
JPMorgan Investment Management, Inc.as of 31 Mar 20255.62m4.53%
SSgA Funds Management, Inc.as of 31 Mar 20255.36m4.32%
American Century Investment Management, Inc.as of 31 Mar 20254.60m3.71%
Palestra Capital Management LLCas of 31 Mar 20254.00m3.22%
Geode Capital Management LLCas of 31 Mar 20253.22m2.60%
Fidelity Management & Research Co. LLCas of 31 Mar 20252.80m2.26%
Southpoint Capital Advisors LPas of 31 Mar 20252.60m2.09%
More ▼
Data from 31 Mar 2025 - 31 Mar 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.